You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm said its test is one-thousandfold more sensitive than conventional SARS-CoV-2 serology tests and could enable earlier antibody detection in patients.
According to the company, its ArrayPlex platform can screen patient samples for anti-SARS-CoV-2 antibodies at a rate of 18,000 samples per instrument per day.
Fluidigm's mass cytometry and microfluidics research product sales were negatively impacted by the COVID-19 pandemic.
The firm said total revenues fell to $424.0 million from $461.4 million in the first quarter of 2019, below analysts' consensus estimate of $444.4 million.
Research institutions in the US and Europe will lead the studies, which will explore different aspects of COVID-19 such as host immune response.
Using protein interaction experiments, researchers identified agents that could disrupt SARS-CoV-2 and human proteins that bind to each other.
Waters posted revenues of $464.9 million for the quarter as the SARS-CoV-2 pandemic drove a drop in sales globally, including a 45 percent decline in China.
The team, which was led by founders of the mass spec firm Purspec, demonstrated the ability of the instrument to quantify levels of the cancer marker Met.
Single-cell and single-molecule proteomics tools developed for the immuno-oncology market are proving useful for studying the immune response in COVID-19.
The alliance will initially focus on rheumatoid arthritis using biomarkers discovered using Nimble's human proteome immunoprofiling technology.
First quarter revenue growth was driven by "unprecedented demand" for molecular biology products for use in COVID-19 testing.
The company expects Q1 revenues of $27.6 million compared to $30.1 million in the year-ago period due to a "significant slowdown" in customer activity.
Tumors from patients who underwent full surgical resection had distinct molecular profiles from those treated with neoadjuvant chemotherapy.
Brain samples from Alzheimer's cases and controls revealed an energy metabolism-related protein network with ties to microglia and astrocyte activity.
Ann Arbor, Michigan-based Celsee offers instruments and consumables for isolating, detecting, and analyzing single cells.
The protein-protein interactions tallied in the project are expected to inform future studies of biology and disease in various tissue and cell types.
The approach uses activity-based nanosensor technology being commercialized by spin-out Glympse Bio to detect dysregulated protease activity linked to disease.
The researchers applied their approach to study the heterogeneity of immune cells and adapted a visualization tool to analyze the data.
Protein profiling on ancient dental enamel samples suggests Homo antecessor was part of a lineage that split from that leading to modern humans and Neanderthals.
The firm delayed reporting final results due to questions of accounting irregularities but found no misconduct and made no changes to its preliminary results.
The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.
NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.
Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.
In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.